These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 24574206)

  • 1. Editorial: molecular insights into systemic sclerosis-associated interstitial lung disease.
    Silver RM; Feghali-Bostwick CA
    Arthritis Rheumatol; 2014 Mar; 66(3):485-7. PubMed ID: 24574206
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular network of important genes for systemic sclerosis-related progressive lung fibrosis.
    Jiao Y; Chen H; Gu T; Wang L; Postlethwaite A; Gu W
    BMC Res Notes; 2015 Oct; 8():544. PubMed ID: 26444860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of Systemic Sclerosis-associated pulmonary fibrosis and pulmonary arterial hypertension. Myth or reality?
    Jimenez SA; Piera-Velazquez S
    Matrix Biol; 2016 Apr; 51():26-36. PubMed ID: 26807760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The arachidonate 5-lipoxygenase activating protein gene polymorphism is associated with the risk of scleroderma-related interstitial lung disease: a multicentre European Scleroderma Trials and Research group (EUSTAR) study.
    Kowal-Bielecka O; Chwiesko-Minarowska S; Bernatowicz PL; Allanore Y; Radstake T; Matucci-Cerinic M; Broen J; Hesselstrand R; Krasowska D; Riemekasten G; Vonk M; Kowalczuk O; Bielecki M; Milewski R; Chyczewski L; Niklinski J; Kowal K
    Rheumatology (Oxford); 2017 May; 56(5):844-852. PubMed ID: 28160477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Stromelysin 2 (Matrix Metalloproteinase 10) as a Novel Mediator of Vascular Remodeling Underlying Pulmonary Hypertension Associated With Systemic Sclerosis.
    Avouac J; Guignabert C; Hoffmann-Vold AM; Ruiz B; Dorfmuller P; Pezet S; Amar O; Tu L; Van Wassenhove J; Sadoine J; Launay D; Elhai M; Cauvet A; Subramaniam A; Resnick R; Hachulla E; Molberg Ø; Kahan A; Humbert M; Allanore Y
    Arthritis Rheumatol; 2017 Nov; 69(11):2209-2221. PubMed ID: 28805015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of urokinase-type plasminogen activator receptor (uPAR) gene induces dermal and pulmonary fibrosis and peripheral microvasculopathy in mice: a new model of experimental scleroderma?
    Manetti M; Rosa I; Milia AF; Guiducci S; Carmeliet P; Ibba-Manneschi L; Matucci-Cerinic M
    Ann Rheum Dis; 2014 Sep; 73(9):1700-9. PubMed ID: 23852693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The genetic predisposition to interstitial lung disease: functional relevance.
    du Bois RM
    Chest; 2002 Mar; 121(3 Suppl):14S-20S. PubMed ID: 11893655
    [No Abstract]   [Full Text] [Related]  

  • 8. Occurrence of an activated, profibrotic pattern of gene expression in lung CD8+ T cells from scleroderma patients.
    Luzina IG; Atamas SP; Wise R; Wigley FM; Choi J; Xiao HQ; White B
    Arthritis Rheum; 2003 Aug; 48(8):2262-74. PubMed ID: 12905481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NLRP1 influences the systemic sclerosis phenotype: a new clue for the contribution of innate immunity in systemic sclerosis-related fibrosing alveolitis pathogenesis.
    Dieudé P; Guedj M; Wipff J; Ruiz B; Riemekasten G; Airo P; Melchers I; Hachulla E; Cerinic MM; Diot E; Hunzelmann N; Caramaschi P; Sibilia J; Tiev K; Mouthon L; Riccieri V; Cracowski JL; Carpentier PH; Distler J; Amoura Z; Tarner I; Avouac J; Meyer O; Kahan A; Boileau C; Allanore Y
    Ann Rheum Dis; 2011 Apr; 70(4):668-74. PubMed ID: 21149496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic determinants of pulmonary fibrosis: evolving concepts.
    Spagnolo P; Grunewald J; du Bois RM
    Lancet Respir Med; 2014 May; 2(5):416-28. PubMed ID: 24815806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung disease associated with progressive systemic sclerosis. Assessment of interlobar variation by bronchoalveolar lavage and comparison with noninvasive evaluation of disease activity.
    Miller KS; Smith EA; Kinsella M; Schabel SI; Silver RM
    Am Rev Respir Dis; 1990 Feb; 141(2):301-6. PubMed ID: 2301848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung involvement in systemic sclerosis sine scleroderma treated by plasma exchange.
    Ferri C; Bernini L; Gremignai G; Latorraca A; Fazzi P; Tavon A; Solfanelli S; Bombardieri S
    Int J Artif Organs; 1992 Jul; 15(7):426-31. PubMed ID: 1516994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel multi-network approach reveals tissue-specific cellular modulators of fibrosis in systemic sclerosis.
    Taroni JN; Greene CS; Martyanov V; Wood TA; Christmann RB; Farber HW; Lafyatis RA; Denton CP; Hinchcliff ME; Pioli PA; Mahoney JM; Whitfield ML
    Genome Med; 2017 Mar; 9(1):27. PubMed ID: 28330499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural features of interstitial lung disease in systemic sclerosis.
    Harrison NK; Myers AR; Corrin B; Soosay G; Dewar A; Black CM; Du Bois RM; Turner-Warwick M
    Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):706-13. PubMed ID: 1892314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Netrin-1 Regulates Fibrocyte Accumulation in the Decellularized Fibrotic Sclerodermatous Lung Microenvironment and in Bleomycin-Induced Pulmonary Fibrosis.
    Sun H; Zhu Y; Pan H; Chen X; Balestrini JL; Lam TT; Kanyo JE; Eichmann A; Gulati M; Fares WH; Bai H; Feghali-Bostwick CA; Gan Y; Peng X; Moore MW; White ES; Sava P; Gonzalez AL; Cheng Y; Niklason LE; Herzog EL
    Arthritis Rheumatol; 2016 May; 68(5):1251-61. PubMed ID: 26749424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CREST syndrome: a variant of progressive systemic sclerosis, associated with interstitial pulmonary fibrosis and malignancy.
    Salvant EE; Carter JM; Armstrong EM; Polk OD; Austin KI
    South Med J; 1988 Sep; 81(9):1185-7. PubMed ID: 3420453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibronectin gene polymorphisms associated with fibrosing alveolitis in systemic sclerosis.
    Avila JJ; Lympany PA; Pantelidis P; Welsh KI; Black CM; du Bois RM
    Am J Respir Cell Mol Biol; 1999 Jan; 20(1):106-12. PubMed ID: 9870923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo investigations on anti-fibrotic potential of proteasome inhibition in lung and skin fibrosis.
    Fineschi S; Bongiovanni M; Donati Y; Djaafar S; Naso F; Goffin L; Argiroffo CB; Pache JC; Dayer JM; Ferrari-Lacraz S; Chizzolini C
    Am J Respir Cell Mol Biol; 2008 Oct; 39(4):458-65. PubMed ID: 18458239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Possible connection between gastroesophageal reflux and interstitial pulmonary fibrosis in patients with systemic sclerosis].
    Savarino E; Ghio M; Marabotto E; Zentilin P; Sammito G; Cittadini G; Sconfienza L; Murolo C; Gemignani L; Indiveri F; Savarino V
    Recenti Prog Med; 2009 Nov; 100(11):512-6. PubMed ID: 20066883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung involvement in systemic sclerosis.
    Silver RM; Miller KS
    Rheum Dis Clin North Am; 1990 Feb; 16(1):199-216. PubMed ID: 2406808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.